We have located links that may give you full text access.
English Abstract
Journal Article
[Identification of a plasmid-mediated AmpC beta-lactamase from clinical isolates of Escherichia coli and Klebsiella pneumoniae].
OBJECTIVE: To investigate the susceptibility and genotype characteristics of Escherichia coli and Klebsiella pneumoniae producing plasmid-mediated AmpC beta lactamase.
METHODS: A total of 110 strains of Escherichia coli and Klebsiella pneumoniae were collected from patients hospitalized in our respiratory ward during January 2002-May 2004. The isolates harboring AmpC beta-lactamase were detected by three-dimensional test, and isoelectric focusing analysis, electroporation, PCR and DNA sequencing were performed to determine the genotypes.
RESULTS: AmpC enzyme was detected in 9.30% (4/43) of the Escherichia coli isolates and 4.48% (3/67) of the Klebsiella pneumoniae isolates. The susceptibility test showed 7 isolates tested were all resistant to cefoxitin, and part of these strains were resistant to the third-generation cephalosporins, beta-lactams/beta-lactamase inhibitors, aztreonam, amikacin and ciprofloxacin, but most of them were susceptible to cefepime and imipenem. Three strains of Klebsiella pneumoniae and 2 strains of Escherichia coli transferred cefoxitin-resistance to recipients by electroporation. Results of PCR and DNA sequencing defined them to be DHA-1 AmpC beta-lactamase.
CONCLUSION: Escherichia coli and Klebsiella pneumoniae producing plasmid-mediated AmpC beta lactamase were isolated from clinical strains in this hospital, and its gene can be transferred horizontally.
METHODS: A total of 110 strains of Escherichia coli and Klebsiella pneumoniae were collected from patients hospitalized in our respiratory ward during January 2002-May 2004. The isolates harboring AmpC beta-lactamase were detected by three-dimensional test, and isoelectric focusing analysis, electroporation, PCR and DNA sequencing were performed to determine the genotypes.
RESULTS: AmpC enzyme was detected in 9.30% (4/43) of the Escherichia coli isolates and 4.48% (3/67) of the Klebsiella pneumoniae isolates. The susceptibility test showed 7 isolates tested were all resistant to cefoxitin, and part of these strains were resistant to the third-generation cephalosporins, beta-lactams/beta-lactamase inhibitors, aztreonam, amikacin and ciprofloxacin, but most of them were susceptible to cefepime and imipenem. Three strains of Klebsiella pneumoniae and 2 strains of Escherichia coli transferred cefoxitin-resistance to recipients by electroporation. Results of PCR and DNA sequencing defined them to be DHA-1 AmpC beta-lactamase.
CONCLUSION: Escherichia coli and Klebsiella pneumoniae producing plasmid-mediated AmpC beta lactamase were isolated from clinical strains in this hospital, and its gene can be transferred horizontally.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app